Condition: Metabolic Dysfunction-associated Steatohepatitis · Sponsor: Eccogene
The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fraction (MRI-PDFF) at Week 12.
This description comes directly from the study's public registry record.
Eccogene Clinical Trials · 86-21-61053022 · contact@eccogene.com
Always discuss trial participation with your own doctor first.
| Arizona Liver Health | Chandler, Arizona, United States | Recruiting |
| Arizona Liver Health - Peoria | Peoria, Arizona, United States | Recruiting |
| Adobe Clinical Research, LLC | Tucson, Arizona, United States | Recruiting |
| Arizona Liver Health - Tucson | Tucson, Arizona, United States | Recruiting |
| Arkansas Gastroenterology, P.A | Little Rock, Arkansas, United States | Recruiting |
| ARcare Center for Clinical Research | Little Rock, Arkansas, United States | Recruiting |
| Om Research | Apple Valley, California, United States | Recruiting |
| ARK Clinical Research - Fountain Valley | Fountain Valley, California, United States | Recruiting |
| Om Research | Lancaster, California, United States | Recruiting |
| Ark Clinical Research | Long Beach, California, United States | Recruiting |
| Knowledge Research Center | Orange, California, United States | Recruiting |
| Om Research | Victorville, California, United States | Recruiting |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07288138